Podrobno

Karakterizacija zlitine AlSi7Mg0,3 : diplomsko delo
ID Sovinc, Martina (Avtor), ID Markoli, Boštjan (Mentor) Več o mentorju... Povezava se odpre v novem oknu, ID Ajlec, Tomaž (Komentor)

.pdfPDF - Predstavitvena datoteka, prenos (2,44 MB)
MD5: FB3FC3950F42767E9CE81FC1E9884D9E
PID: 20.500.12556/rul/215110df-8d68-4ad0-83dd-526cf2533058

Jezik:Slovenski jezik
Ključne besede:aluminijeva zlitina, tlačno litje, mehanske lastnosti, karakterizacija
Vrsta gradiva:Diplomsko delo/naloga
Organizacija:NTF - Naravoslovnotehniška fakulteta
Kraj izida:Ljubljana
Založnik:[M. Sovinc]
Leto izida:2017
Št. strani:VI, 37 f.
PID:20.500.12556/RUL-94461 Povezava se odpre v novem oknu
UDK:669.2/.8
COBISS.SI-ID:1666143 Povezava se odpre v novem oknu
Datum objave v RUL:29.08.2017
Število ogledov:9325
Število prenosov:711
Metapodatki:XML DC-XML DC-RDF
:
SOVINC, Martina, 2017, Karakterizacija zlitine AlSi7Mg0,3 : diplomsko delo [na spletu]. Diplomsko delo. Ljubljana : M. Sovinc. [Dostopano 30 marec 2025]. Pridobljeno s: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=slv&id=94461
Kopiraj citat
Objavi na:Bookmark and Share

Sekundarni jezik

Jezik:Angleški jezik
Ključne besede:aluminium alloy, die-casting, mechanical properties, characterization

Podobna dela

Podobna dela v RUL:
  1. Systematic review and meta-analysis of observational studies evaluating treatment outcomes in patients with metastatic non-small-cell lung cancer on first-line immune checkpoint inhibitors therapy
  2. Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
  3. Effectivness and safety of immunotherapy in patients with advanced non-small cell lung cancer in second line treatment at the University Clinic Golnik
  4. Evaluation of possible pembrolizumab dosing regimen racionalisation in advanced non-small cell lung cancer
  5. ǂThe ǂpotential of immunotherapies in the treatment of lung cancer
Podobna dela v drugih slovenskih zbirkah:
  1. ǂThe ǂrole of immune checkpoint inhibitors in the treatment of cancer of unknown origin
  2. Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
  3. Febrile neutropenia and grade 3/4 neutropenia in daily practice of adjuvant chemotherapy for non-small-cell lung cancer
  4. Advances in the therapy with immune-check point inhibitors (ICI) in non-small cell lung cancer (NSCLC) in 2022
  5. Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy

Nazaj